Ali Azimi1, Kimberley L Kaufman2,3, Marina Ali1, Steven Kossard4, Pablo Fernandez-Penas5. 1. Department of Dermatology, Westmead Hospital, The University of Sydney, Westmead, NSW, Australia. 2. School of Molecular Bioscience, Faculty of Science, The University of Sydney, Camperdown, NSW, Australia. 3. Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia. 4. Dermatopathology, Skin and Cancer Foundation Australia, Darlinghurst, NSW, Australia. 5. Department of Dermatology, Westmead Hospital, The University of Sydney, Westmead, NSW, Australia pablo.fernandezpenas@sydney.edu.au.
Abstract
BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is a common type of skin cancer but there are no comprehensive proteomic studies on this entity. MATERIALS AND METHODS: We employed liquid chromatography coupled with tandem mass spectrometry (MS/MS) using formalin-fixed paraffin-embedded (FFPE) cSCC material to study the tumor and normal skin tissue proteomes. Ingenuity Pathway Analysis (IPA) was used to interpret the role of altered proteins in cSCC pathophysiology. Results were validated using the Human Protein Atlas and Oncomine database in silico. RESULTS: Of 1,310 unique proteins identified, expression of an average of 144 and 88 proteins were significantly (p<0.05) increased and decreased, respectively, in the tumor samples compared to their normal counterparts. IPA analysis revealed disruptions in proteins associated with cell proliferation, apoptosis, and migration. In silico analysis confirmed that proteins corresponding to 12 antibodies, and genes corresponding to 18 proteins were differentially expressed between the two categories, validating our proteomic measurements. CONCLUSION: Label-free MS-based proteomics is useful for analyzing FFPE cSCC tissues. Copyright
BACKGROUND:Cutaneous squamous cell carcinoma (cSCC) is a common type of skin cancer but there are no comprehensive proteomic studies on this entity. MATERIALS AND METHODS: We employed liquid chromatography coupled with tandem mass spectrometry (MS/MS) using formalin-fixed paraffin-embedded (FFPE) cSCC material to study the tumor and normal skin tissue proteomes. Ingenuity Pathway Analysis (IPA) was used to interpret the role of altered proteins in cSCC pathophysiology. Results were validated using the Human Protein Atlas and Oncomine database in silico. RESULTS: Of 1,310 unique proteins identified, expression of an average of 144 and 88 proteins were significantly (p<0.05) increased and decreased, respectively, in the tumor samples compared to their normal counterparts. IPA analysis revealed disruptions in proteins associated with cell proliferation, apoptosis, and migration. In silico analysis confirmed that proteins corresponding to 12 antibodies, and genes corresponding to 18 proteins were differentially expressed between the two categories, validating our proteomic measurements. CONCLUSION: Label-free MS-based proteomics is useful for analyzing FFPE cSCC tissues. Copyright
Authors: Karim Rezaul; Michael Murphy; Deborah H Lundgren; Lori Wilson; David K Han Journal: Pigment Cell Melanoma Res Date: 2010-12 Impact factor: 4.693
Authors: Lingbao Ai; Wan-Ju Kim; Tae-You Kim; C Robert Fields; Nicole A Massoll; Keith D Robertson; Kevin D Brown Journal: Cancer Res Date: 2006-08-15 Impact factor: 12.701
Authors: Hisham Bazzi; Katherine A Fantauzzo; Gavin D Richardson; Colin A B Jahoda; Angela M Christiano Journal: Dev Dyn Date: 2007-04 Impact factor: 3.780
Authors: de Lima Vazquez Vinicius; Cristovam Scapulatempo; Natalia Martins Perpetuo; Faheez Mohamed; Teóclito Sachetto de Carvalho; Antônio Talvane Torres de Oliveira; José Getúlio Martins Segalla; André Lopes Carvalho Journal: J Skin Cancer Date: 2011-05-19
Authors: Arvin M Gouw; Katherine Margulis; Natalie S Liu; Sudha J Raman; Anthony Mancuso; Georgia G Toal; Ling Tong; Adriane Mosley; Annie L Hsieh; Delaney K Sullivan; Zachary E Stine; Brian J Altman; Almut Schulze; Chi V Dang; Richard N Zare; Dean W Felsher Journal: Cell Metab Date: 2019-08-22 Impact factor: 27.287
Authors: Melanie Christine Föll; Matthias Fahrner; Victor Oginga Oria; Markus Kühs; Martin Lothar Biniossek; Martin Werner; Peter Bronsert; Oliver Schilling Journal: Clin Proteomics Date: 2018-03-06 Impact factor: 3.988
Authors: Jeremy A Herrera; Venkatesh Mallikarjun; Silvia Rosini; Maria Angeles Montero; Craig Lawless; Stacey Warwood; Ronan O'Cualain; David Knight; Martin A Schwartz; Joe Swift Journal: Clin Proteomics Date: 2020-06-17 Impact factor: 3.988